The Efficacy of Schema Therapy in the treatment of diabetes

The Efficacy of Schema Therapy on Alexithymia, Cognitive Flexibility, Body Image and Food Craving Individuals with Type 2 Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20251201068177N1

Enrollment

Registered

2025-12-31

Start date

2025-10-12

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention groups: Participants allocated to the intervention group will receive group-based schema therapy in addition to standard medical care. The intervention will consist of eig

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Eligible individuals must be between 30 and 60 years old. Have at least a high school diploma Registration will only be done after participants provide written informed consent. Patients with current psychiatric disorders or taking psychotropic medications are not eligible to participate in the study.

Exclusion criteria

Exclusion criteria: Unforeseen or unexpected events occur Absence of more than 2 sessions

Design outcomes

Primary

Measure	Time frame
The average score obtained from the alexithymia questionnaire in the study subjects is considered as the primary outcome of the study, the sample size is also calculated in the initial proposal based on this variable, and other variables are examined as secondary outcomes. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of the Toronto Alexithymia Scale-20.	—

Measure

Time frame

The average score obtained from the alexithymia questionnaire in the study subjects is considered as the primary outcome of the study, the sample size is also calculated in the initial proposal based on this variable, and other variables are examined as secondary outcomes. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of the Toronto Alexithymia Scale-20.

—

Secondary

Measure	Time frame
Average score obtained from the Cognitive Flexibility Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of Dennis and Vanderwaal's Cognitive Flexibility Questionnaire.;Average score obtained from the Body Image Concern Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Pre-test (before intervention) and immediate post-test after intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of Littleton's body image concerns.;Average score obtained from the Food Craving Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of the Sidabnitto Food Craving Trait Questionnaire (PFQ_T).	—

Measure

Time frame

Average score obtained from the Cognitive Flexibility Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of Dennis and Vanderwaal's Cognitive Flexibility Questionnaire.;Average score obtained from the Body Image Concern Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Pre-test (before intervention) and immediate post-test after intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of Littleton's body image concerns.;Average score obtained from the Food Craving Questionnaire in adults with type 2 diabetes after an 8-week schema therapy intervention. Timepoint: Baseline (pre-intervention) and immediately post-intervention (after 8 weeks of schema therapy). Method of measurement: Valid Persian version of the Sidabnitto Food Craving Trait Questionnaire (PFQ_T).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Fathi

Islamic Azad University, Najafabad Branch

zahra.fathi2280@gmail.com+98 31 3744 8620

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026